Enveda Biosciences
Database & File Management Software · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5700 Flatiron Pkwy, Boulder, Colorado, 8...Website
www.envedabio.comRevenue
$19.4 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
4
2
2
2
2
About Enveda Biosciences
Founded in 2019, Based out of Boulder, CO, is a database provider of anthropological, chemical, and biological data from medicinal plants.Explore more
Popular SearchesEnveda BiosciencesEnveda Biosciences IncSIC Code 73,738NAICS Code 51,519Show moreEnveda Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enveda Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Enveda Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Enveda Biosciences
Click to see if Enveda Biosciences had a recent Job posting/layoffs
Check out if Enveda Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Enveda Biosciences has new funding data
Product Launch: Get notified when Enveda Biosciences launches new products
Enveda Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Enveda Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Enveda Biosciences
Find 2 more new buyers
Compare Similar Companies to Enveda Biosciences
Compare insights from companies similar to Enveda Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enveda Biosciences is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Enveda Biosciences is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Enveda Biosciences.
Enveda Biosciences financials insights
Gather financial insights about Enveda Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$4.9M
2021
Series A
$51M
2024
Series B
$230M
Enveda Biosciences Tech Stack
A closer look at the technologies used by Enveda Biosciences
Most Recent Scoops
Hiring Plans
Enveda Biosciences has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
New Hire
Executive Move
Enveda Biosciences has announced that Jason Kim has joined the organization as Chief Financial Officer.
Open Position
Open Position
Left Company
Executive Move
Executive Moves, Left Company
Enveda Biosciences News & Media
Jason Kim named CFO at Enveda - BizWest
Jason Kim has been appointed chief financial officer at Enveda Biosciences, a biotechnology company using artificial intelligence to translate life’s chemistry into new medicines.Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates
BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a biotechnology company using AI to translate nature into new medicines, announced today an oversubscribed $130 million Series C funding round led by Kinnevik and FPV with participation from new and existing investors Baillie Gifford, Premji Invest, Lingotto Innovation, Lux Capital, Dimension Capital, True Ventures, Cresset Partners, The Nature Conservancy, and Henry R. Kravis. This brings the company's total funding to $360 million. The new funding willEnveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials
BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a biotechnology company using AI to translate nature into new medicines, announced today that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for its first asset targeting atopic dermatitis and other inflammatory conditions. The company also announced it has entered this candidate, named ENV-294, into a Phase I clinical trial, with the first patient dosed at the end of October. The novel oral first-inEnveda Biosciences Hires Chief Medical Officer to Advance Its Rich Pipeline of Therapeutic Programs into the Clinic
BOULDER, Colo.--(BUSINESS WIRE)--Enveda Biosciences (“Enveda”), a biotechnology company using AI to translate nature into new medicines, announced today the appointment of José Trevejo M.D. Ph.D., as Chief Medical Officer and Head of Clinical Pipeline Strategy. In this role, Dr. Trevejo will lead the clinical organization and oversee the advancement of Enveda’s robust pipeline that spans multiple therapeutic areas. Dr. Trevejo joins Enveda following a string of recent successes, most recently a
Read more news
Top Database & File Management Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enveda Biosciences
Sign Up For FreeTo access detailed company insights
Founded in 2019, Based out of Boulder, CO, is a database provider of anthropological, chemical, and biological data from medicinal plants.... Read More
